12 August 2025
Following the NW London IMOC meeting on 16th July, the interim position statement on prescribing semaglutide (Wegovy®) and tirzepatide (Mounjaro®) for weight management within the NHS in North West London has now been published here.
This guidance should be read in conjunction with the NW London update on tirzepatide and its use within the NHS in NW London.
For further support with signposting patients, please refer to the publication titled 'Weight Management Support in North West London'.